Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Documents in this section are publicly available.

Before downloading these documents, please read our Online Code of Conduct.


This webpage is based on the chapters of the WMDA handbook.


General Organisation of a Registry

WMDA StandardTitle and link to documentExplanationStatus

3.13

4.09

Unrelated hematopoietic stem cell donors as research subjects

Bone Marrow Transplantation (2011), 46: 10-13

Discuss various implications of research participation of unrelated stem cell donors in research protocols.Current (2017)
10.13

Donor and liability of donor registries, donor centres and collection centres-recommendations

Bone Marrow Transplantation (2004), 33: 467-470

The paper outlines the ethical aspects of liability of involved parties and the need for insurance coverage. The article has shortcoming with the respect to legal advices.

Under review (2017), for more details:

Annette Rasche


GRID

2.11

2.11.1

WMDA Quality Manual

Related donors

Family donor care management: principles and recommendations

Bone Marrow Transplantation (2010) 45: 1269-1273

This document hopes to encourage increased collaboration between those caring for related and unrelated donors, and build on the extensive work, which has already been undertaken in this field to homogenize care.Current (2017)



Recruitment of volunteer donors

WMDA StandardTitle and link to documentExplanationStatus

3.22

3.22.2

Guidance for assessing the medical suitability for adult volunteer donors

The guidance below reflects the consensus opinion provided by the WMDA donor medical suitability committee. The purpose of this guidance is to provide globally harmonised medical assessment criteria which simultaneously protect the interest of donors whilst ensuring the safety of cellular products across international boundaries.

Current (2017)


3.02

Qualifications and training of adult stem cell donor recruiters: recommendations by the World Marrow Donor Association

Bone Marrow Transplantation (2013) 48: 1480150

Paper providing recommendations regarding qualifications and training of recruiters

Key Performance Indicators for Registries

3.03, 3.04, 3.09, 6.07, 6.07.1, 3.24, 10.11, 10.13

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

Bone Marrow Transplantation (2010) 45: 832-838

This paper is providing information about the donor care standards of the WMDA. The paper has been published in 2010, the wording of the WMDA Standards might have changed over time.Current (2017)





Donor search request

WMDA StandardTitle and link to documentExplanationStatus


Recommendation on the training of staff performing patient donor search and HLA matching activities




Suggested procedures for international unrelated search

7.01

WMDA Guidelines for subsequent donations following initial BM or PBSCs

Bone Marrow Transplantation (2011) 46: 1409-1412

This guideline is intended to outline where subsequent donations would routinely be considered appropriate (from the donor's point-of-view), as well as the frequency and timing of such donations.

Under review, see https://share.wmda.info/x/8qWbEw

for more information

3.03, 3.06, 6.06

Donor commitment and patient needs

Bone Marrow Transplantation (2004) 33: 225-230

This paper describes ethical issues related to the donation of hematopoietic stem cell products with respect to recruitment, evaluation, workup, and follow-up of unrelated donors.Current (2017)





Collection and transportation

WMDA StandardTitle and link to documentExplanationStatus

8.05

Recommendation for recombinant human G-CSF (G-CSF) that stem cell registries can use - the use of biosimilar G-CSF

WMDA recommendation on the use of biosimilar filgrastimsCurrent (2018)
3.03

Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.

Blood (2010) 117: 21-25

This paper describes the reasons that the WMDA continues to believe that HSC donors should not be paid due to ethical concerns raised by remuneration, potential to damage the public will to act altruistically, the potential for coercion and exploitation of donors, increased risk to patients, harm to local transplantation programs and international stem cell exchange, and the possibility of benefiting some patients while disadvantaging others.Current (2017)
1.08

Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation

Bone Marrow Transplantation (2018)

This paper describes the general requirements and recommendations for collaboration with the collection and apheresis centers and define critical procedures for the collection of the stem cell product, such as information session, medical assessment, product collection, quality controls, product handover for transportation, and donor follow-up. The specific guidelines are accompanied by detailed checklists and forms that can be found in Supplementary Information and may be used during an initial or follow-up on-site or paper-based audit. For more information you can visit: https://share.wmda.info/x/OAKQEQCurrent (2018)

Labeling


Post-donation

WMDA StandardTitle and link to documentExplanationStatus


Towards a global system







Cord Blood Banking

WMDA StandardTitle and link to documentExplanationStatus

















Information technology and data management

WMDA StandardTitle and link to documentExplanationStatus

2.11.2

World marrow donor association crisis response, business continuity, and disaster recovery guidelines.



Current (2017)
























Finance and administration

WMDA StandardTitle and link to documentExplanationStatus







Publications in partnership with other professional societies

WMDA StandardTitle and link to documentExplanationStatus

9.02

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Global consensus document to perform long-term follow up on donors till 10 years after donation.Current (2017)






Archived Publications

WMDA StandardTitle and link to documentExplanationStatus

3.04, 3.05, 3.06, 3.09, 3.10.1, 3.11, 3.11.1, 3.13, 3.15

Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.

Bone Marrow Transplantation (2003) 31: 539-545

This is a checklist to set up an informed consent at the various stages. The paper has been replaced by the WMDA Guidance to explain the WMDA Standards. The guidance can be found at: https://share.wmda.info/x/0wB7CwOut of date


Standards, regulations  and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

Bone Marrow Transplantation (2010), 45:819-824

WMDA has developed online documentation to explain the accreditation process, which is available at WMDA Share under the pillar: 'Ensuring Quality'Out of date

International exchange of cord blood units; the registry aspects

Bone Marrow Transplantation (2010), 45: 825-831

Replaced by chapter 6 of the WMDA handbook: a gift of lifeOut of date
8.05

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors: position of World Marrow Donor Association.

Haematologica (2011): 96:942-943

The aim of this paper is to review the basis of regulatory approval of the biosimilar G-CSF agents, including the available safety data, with reference to the indication for mobilization of PBSC in normal donors and to make recommendations based on these.

The recommendation has been updated in 2017.

Out of date

























Page Tree
root@home
excerpttrue